Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation

被引:0
|
作者
Toft-Petersen, Anne Pernille [1 ]
Lee, Christina J. -y. [1 ]
Phelps, Matthew [2 ]
Ozenne, Brice [3 ,4 ]
Gerds, Thomas Alexander [5 ]
Torp-Pedersen, Christian [1 ,2 ,5 ]
机构
[1] Univ Copenhagen, Nordsjaellands Hosp, Dept Cardiol & Clin Res, Hillerod, Denmark
[2] Danish Heart Fdn, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Sect Biostat, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit & BrainDrugs, Copenhagen, Denmark
[5] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
来源
PLOS ONE | 2024年 / 19卷 / 11期
关键词
ORAL ANTICOAGULANTS; RISK SCORES; STROKE; WARFARIN; HEMORRHAGE; THERAPY; REGISTRY; SCHEMES; ORBIT;
D O I
10.1371/journal.pone.0312294
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Anticoagulation in atrial fibrillation (AF) increases the risk of major bleeding. No predictive model has hitherto provided estimates of the absolute risk for individual patients. Aim To predict the individual 1-year risk of major bleeding in patients with AF taking anticoagulants and evaluate the importance of individual risk factors. Design A nationwide register-based cohort study. Participants Danish patients with first-time non-valvular AF who redeemed anticoagulants within 7 days after diagnosis. Method The individual absolute risk of major bleeding was estimated from a logistic regression model (the Calculator of Absolute Bleeding Risk/CABS model) utilising the same risk factors as HAS-BLED, except allowing non-linear age effects, and allowing effect modification of all factors according to history of bleeding. The logistic regression was assessed in term of discrimination using the Area Under the ROC curve (AUC) and calibration. Results Among 76,102 patients with AF redeeming anticoagulants, 2,406 suffered a major bleeding within 1 year. History of bleeding was the strongest predictor, and age significantly modified the risk. The CABS model superseded HAS-BLED score with regards to discrimination (AUC 0.646 vs 0.615, p<0.001) and calibrated well. A typical male patient was 70-years old without any risk factors and he had a 1-year bleeding risk of 1.4% (1.2; 1.6) while a typical female patient was 73-years old, had hypertension and a 1-year bleeding risk of 2.2% (1.9;2.6). Conclusion We propose CABS as a tool for prediction of individual absolute risks of major bleeding in patients with AF taking anticoagulant. The predicted absolute risk can be used for patient counselling.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
    Ording, Anne Gulbech
    Sogaard, Mette
    Skjoth, Flemming
    Grove, Erik Lerkevang
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    CANCER MEDICINE, 2021, 10 (13): : 4405 - 4414
  • [32] Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
    Feldeisen, Thane
    Alexandris-Souphis, Constantina
    Haymart, Brian
    Kong, Xiaowen
    Kline-Rogers, Eva
    Handoo, Faheem
    Scott, Kaatz
    Ali, Mona
    Kozlowski, Jay
    Shah, Vinay
    Krol, Gregory
    Froehlich, James B.
    Barnes, Geoffrey D.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 542 - 547
  • [33] Anticoagulation in Atrial Fibrillation
    Hohnloser, Stefan
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (14) : 963 - 969
  • [34] Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review
    Milling, Truman J.
    Fromm, Christian
    Ganetsky, Michael
    Pallin, Daniel J.
    Cong, Julie
    Singer, Adam J.
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (05) : 531 - 540
  • [35] Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan
    Miyamoto, Susumu
    Ikeda, Takanori
    Ogawa, Satoshi
    Kitazono, Takanari
    Nakagawara, Jyoji
    Minematsu, Kazuo
    Murakawa, Yuji
    Iwashiro, Sanghun
    Takeichi, Makiko
    Kidani, Yoko
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Sato, Shoichiro
    Yamanaka, Satoshi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04)
  • [36] Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation
    Dakay, Katarina
    Chang, Andrew D.
    Hemendinger, Morgan
    Cutting, Shawna
    McTaggart, Ryan A.
    Jayaraman, Mahesh V.
    Chu, Antony
    Panda, Nikhil
    Song, Christopher
    Merkler, Alexander
    Gialdini, Gino
    Kummer, Benjamin
    Lerario, Michael P.
    Kamel, Hooman
    Elkind, Mitchell S. V.
    Furie, Karen L.
    Yaghi, Shadi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (01) : 192 - 197
  • [37] Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
    Lip, Gregory Y. H.
    Clementy, Nicolas
    Pericart, Lauriane
    Banerjee, Amitava
    Fauchier, Laurent
    STROKE, 2015, 46 (01) : 143 - 150
  • [38] Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation
    Bryk, Agata Hanna
    Plens, Krzysztof
    Undas, Anetta
    CARDIOLOGY JOURNAL, 2017, 24 (05) : 477 - 483
  • [39] Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
    Beshir, S. A.
    Aziz, Z.
    Yap, L. B.
    Chee, K. H.
    Lo, Y. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 209 - 219
  • [40] Outcomes following major bleeding in atrial fibrillation
    Nadarajah, Ramesh
    Gale, Chris P.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2021, 7 (02) : 119 - 120